Found 683 matching trials
Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )
PHASE2This is an open-label, single-arm, single-cohort, prospective clinical stud...
Location
Departmeng of Urology, Peking University First Hospita
Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI
PHASE3This is a Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase ...
Location
Shanghai Pulmonary Hospital
A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients
PHASE1This is a Phase 1, open-label, dose escalation study in patients with advan...
Toripalimab Combined With Chemoradiotherapy in Patients With Locoregionally-advanced Nasopharyngeal Carcinoma
PHASE2This is an open-label, parallel controlled, phase IIa exploratory study tha...
Location
Multiple Locations
Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX Regimen
PHASE2This is an open, single-arm, single-center, prospective phase II clinical s...
First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC
PHASE2Our aim in this study was to evaluate the efficacy and safety of etoposide ...
Location
Enze Hospital, affiliated Taizhou Hospital of Wenzhou Medical University
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC
PHASE3This phase III randomized trial evaluates PD-1 inhibitor plus chemotherapy ...
Location
Sun Yat-sen University Cancer Center
GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma
PHASE2Nasopharyngeal carcinoma (NPC) has a low incidence rate in children, accoun...
Location
Sun Yat-sen University Cancer Center
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
PHASE2The NeoScorch HN study is a single institution multisite phase II trial inc...
Location
Johns Hopkins Hospital East Baltimore
Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS
PHASE2The objective of this Phase II, open-label, multicenter, non-randomised con...
Location
Multiple Locations